Home

Latest News

Web Stories

WhatsApp
Market News

INMB Stock Earnings: INmune Bio Misses EPS, Misses Revenue for Q4 2023

Avatar photo
by Ron Finklestien
Published On: March 28, 2024 9:24 pm







INmune Bio Q4 2023: A Financial Stumble in the Dark

INmune Bio 2023 Q4 Earnings Report

INMB stock - INMB Stock Earnings: INmune Bio Misses EPS, Misses Revenue for Q4 2023

Source: iQoncept / Shutterstock

The Financial Misstep of INmune Bio

INmune Bio (NASDAQ:INMB) recently unveiled its financial performance for the final quarter of 2023:

  • Reported earnings per share stood at -47 cents, falling short of the projected -44 cents.
  • Revenue figures showed $28,000, a notable 30% dip compared to the anticipated $40,000.

InvestorPlace Earnings, powered by TradeSmith data, delivers automated updates on quarterly earnings. By swiftly sharing crucial insights like EPS and revenue, it offers a snapshot of a company’s performance against analyst forecasts. These reports are generated without human intervention to swiftly disseminate the latest financials. To flag any concerns or inaccuracies, reach out to us at [email protected].

Article printed from InvestorPlace Media, https://investorplace.com/earning-results/2024/03/inmb-stock-earnings-inmune-bio-for-q4-of-2023/.

©2024 InvestorPlace Media, LLC


The free Daily Market Overview 250k traders and investors are reading

Read Now

Latest Stories

Billionaire Michael Platt’s Strategic Investment Aligns with Warren Buffett’s Philosophy

Predictions for Tesla Stock Price in Three Years

The Ultimate Stock for Long-Term Investment Success

Daily market headlines that move the needle.

Categories

Today’s Market

Most Popular

Market News

Links

About Us

Contact Us

Disclaimer

Privacy policy

Follow Us On

Follow Us On Social Media

© wallstreetwaves.com • All rights reserved